CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -594.78 Thousand USD | -580.78% |
| 2020 | -87.36 Thousand USD | 98.25% |
| 2019 | -4.97 Million USD | 22.86% |
| 2018 | -6.45 Million USD | -26.01% |
| 2017 | -5.12 Million CAD | -177.36% |
| 2016 | -1.84 Million CAD | -1345.79% |
| 2015 | -127.75 Thousand USD | -0.88% |
| 2014 | -126.64 Thousand CAD | 21.64% |
| 2013 | -161.61 Thousand CAD | 24.74% |
| 2012 | -214.74 Thousand CAD | -37.97% |
| 2011 | -155.64 Thousand CAD | -0.48% |
| 2010 | -154.9 Thousand CAD | -5.74% |
| 2009 | -146.49 Thousand CAD | 38.72% |
| 2008 | -239.06 Thousand CAD | 60.25% |
| 2007 | -601.47 Thousand CAD | 12.4% |
| 2006 | -686.59 Thousand CAD | -88.09% |
| 2005 | -365.03 Thousand CAD | -58.59% |
| 2004 | -230.18 Thousand CAD | 59.39% |
| 2003 | -566.84 Thousand CAD | -158.09% |
| 2002 | -219.63 Thousand CAD | -158.0% |
| 2001 | -85.12 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | -109.25 Thousand USD | 24.01% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q1 | -143.78 Thousand USD | 31.93% |
| 2022 Q3 | -109.99 Thousand USD | -0.67% |
| 2022 FY | - USD | 100.0% |
| 2021 Q2 | 116.6 Thousand USD | 136.39% |
| 2021 Q1 | -320.42 Thousand USD | -170.05% |
| 2021 Q3 | -179.74 Thousand USD | -254.15% |
| 2021 Q4 | -211.21 Thousand USD | -17.51% |
| 2021 FY | -594.78 Thousand USD | -580.78% |
| 2020 Q2 | -107.81 Thousand USD | 58.67% |
| 2020 Q3 | -176.13 Thousand USD | -63.37% |
| 2020 Q4 | 457.45 Thousand USD | 359.71% |
| 2020 FY | -87.36 Thousand USD | 98.25% |
| 2020 Q1 | -260.86 Thousand USD | 75.44% |
| 2019 FY | -4.97 Million USD | 22.86% |
| 2019 Q4 | -1.06 Million USD | -344.07% |
| 2019 Q3 | -239.21 Thousand USD | 85.36% |
| 2019 Q1 | -2.04 Million USD | 43.9% |
| 2019 Q2 | -1.63 Million USD | 20.03% |
| 2018 Q4 | -3.64 Million USD | -620.53% |
| 2018 Q3 | -505.64 Thousand CAD | 62.15% |
| 2018 Q2 | -1.33 Million CAD | -61.59% |
| 2018 Q1 | -826.7 Thousand CAD | 50.69% |
| 2018 FY | -6.45 Million USD | -26.01% |
| 2017 Q1 | -1.56 Million CAD | -1339.52% |
| 2017 Q3 | -996.34 Thousand CAD | -8.93% |
| 2017 Q4 | -1.67 Million CAD | -68.27% |
| 2017 FY | -5.12 Million CAD | -177.36% |
| 2017 Q2 | -914.66 Thousand CAD | 41.73% |
| 2016 FY | -1.84 Million CAD | -1345.79% |
| 2016 Q4 | -109.04 Thousand USD | 91.41% |
| 2016 Q3 | -1.26 Million USD | -2963.56% |
| 2016 Q1 | -33 Thousand USD | 2.14% |
| 2016 Q2 | -41.43 Thousand USD | -25.53% |
| 2015 Q3 | -41.17 Thousand CAD | -45.75% |
| 2015 Q4 | -33.73 Thousand USD | 18.07% |
| 2015 Q2 | -28.24 Thousand CAD | -5.08% |
| 2015 Q1 | -26.88 Thousand CAD | 11.02% |
| 2015 FY | -127.75 Thousand USD | -0.88% |
| 2014 Q2 | -39.45 Thousand CAD | -57.77% |
| 2014 Q3 | -33.95 Thousand CAD | 13.94% |
| 2014 Q4 | -30.21 Thousand CAD | 11.02% |
| 2014 FY | -126.64 Thousand CAD | 21.64% |
| 2014 Q1 | -25 Thousand CAD | 38.51% |
| 2013 Q2 | -44.69 Thousand CAD | -24.94% |
| 2013 FY | -161.61 Thousand CAD | 24.74% |
| 2013 Q4 | -40.66 Thousand CAD | -11.84% |
| 2013 Q3 | -36.36 Thousand CAD | 18.65% |
| 2013 Q1 | -35.77 Thousand CAD | 26.71% |
| 2012 FY | -214.74 Thousand CAD | -37.97% |
| 2012 Q3 | -57.04 Thousand CAD | 0.19% |
| 2012 Q4 | -48.81 Thousand CAD | 14.43% |
| 2012 Q1 | -37.8 Thousand CAD | 35.34% |
| 2012 Q2 | -57.15 Thousand CAD | -51.19% |
| 2011 Q1 | -46.29 Thousand CAD | -172.28% |
| 2011 Q2 | -24.32 Thousand CAD | 47.46% |
| 2011 Q3 | -31.12 Thousand CAD | -27.94% |
| 2011 FY | -155.64 Thousand CAD | -0.48% |
| 2011 Q4 | -58.46 Thousand CAD | -87.87% |
| 2010 Q4 | 64.04 Thousand CAD | 298.72% |
| 2010 Q3 | -32.23 Thousand CAD | 0.72% |
| 2010 FY | -154.9 Thousand CAD | -5.74% |
| 2010 Q2 | -32.46 Thousand CAD | 0.0% |
| 2009 FY | -146.49 Thousand CAD | 38.72% |
| 2008 Q3 | -3.78 Million CAD | -9293.18% |
| 2008 Q4 | 402.13 Thousand CAD | 110.62% |
| 2008 Q2 | -40.31 Thousand CAD | 23.76% |
| 2008 Q1 | -52.87 Thousand CAD | 72.61% |
| 2008 FY | -239.06 Thousand CAD | 60.25% |
| 2007 Q3 | -70.05 Thousand CAD | 73.9% |
| 2007 Q2 | -268.38 Thousand CAD | -315.12% |
| 2007 Q1 | -64.65 Thousand CAD | -68.2% |
| 2007 FY | -601.47 Thousand CAD | 12.4% |
| 2007 Q4 | -193.06 Thousand CAD | -175.58% |
| 2006 Q3 | -73.85 Thousand CAD | 5.02% |
| 2006 Q4 | -38.43 Thousand CAD | 47.95% |
| 2006 Q1 | -475.75 Thousand CAD | -294.18% |
| 2006 Q2 | -77.75 Thousand CAD | 83.66% |
| 2006 FY | -686.59 Thousand CAD | -88.09% |
| 2005 Q2 | -51.46 Thousand CAD | 36.14% |
| 2005 Q4 | -120.69 Thousand CAD | 35.23% |
| 2005 FY | -365.03 Thousand CAD | -58.59% |
| 2005 Q3 | -186.34 Thousand CAD | -262.09% |
| 2005 Q1 | -80.58 Thousand CAD | -13.91% |
| 2004 Q4 | -70.74 Thousand CAD | -65.69% |
| 2004 Q3 | -42.69 Thousand CAD | 6.76% |
| 2004 Q2 | -45.79 Thousand CAD | 30.33% |
| 2004 FY | -230.18 Thousand CAD | 59.39% |
| 2004 Q1 | -65.72 Thousand CAD | 84.43% |
| 2003 Q1 | -56.15 Thousand CAD | 53.88% |
| 2003 Q2 | -45.28 Thousand CAD | 19.35% |
| 2003 Q3 | -38.75 Thousand CAD | 14.43% |
| 2003 Q4 | -422.03 Thousand CAD | -989.06% |
| 2003 FY | -566.84 Thousand CAD | -158.09% |
| 2002 Q1 | -36.75 Thousand CAD | 0.0% |
| 2002 FY | -219.63 Thousand CAD | -158.0% |
| 2002 Q2 | -43.28 Thousand CAD | -17.75% |
| 2002 Q4 | -121.74 Thousand CAD | -176.92% |
| 2002 Q3 | -43.96 Thousand CAD | -1.57% |
| 2001 FY | -85.12 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.91 Million USD | 100.0% |
| Polarean Imaging plc | -12.55 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 100.0% |
| Avitar, Inc. | 2.73 Million USD | 100.0% |
| AVITA Medical, Inc. | -40.4 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | 100.0% |
| Össur hf. | 87.46 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.65 Million USD | 100.0% |
| QHSLab, Inc. | -240.15 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.79 Million USD | 100.0% |
| Össur hf. | 87.46 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 100.0% |
| Escalon Medical Corp. | -104.47 Thousand USD | 100.0% |
| Aurora Spine Corporation | -446.19 Thousand USD | 100.0% |
| BrainsWay Ltd. | -4.92 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | -9.45 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -516.16 Million USD | 100.0% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.43 Million USD | 100.0% |
| Theraclion SA | -3.48 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | 100.0% |
| Positron Corporation | -1.36 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -2.06 Million USD | 100.0% |
| Lombard Medical, Inc. | -29.33 Million USD | 100.0% |
| ALR Technologies Inc. | -2.94 Million USD | 100.0% |
| Stratec SE | 25.26 Million USD | 100.0% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 100.0% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -540 Thousand USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.66 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.45 Million USD | 100.0% |
| Ingen Technologies, Inc. | -1.61 Million USD | 100.0% |
| Odyssey Group International, Inc. | 14.26 Million USD | 100.0% |
| United American Healthcare Corporation | -67 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | 100.0% |
| Urologix, Inc. | -6.93 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 100.0% |
| SS Innovations International, Inc. | -20.66 Million USD | 100.0% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | 100.0% |
| Smith & Nephew plc | 425 Million USD | 100.0% |
| NIOX Group Plc | 4.6 Million USD | 100.0% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 100.0% |
| Broncus Holding Corporation | -33.22 Million USD | 100.0% |
| Brain Scientific Inc. | -9.6 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 100.0% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | 100.0% |